Venøs tromboembolisk sygdom ved COVID-19

Maja Hellfritzsch; Thomas Kümler; Anette Tarp Hansen; Marianne Tang; Kasper Gymoese Berthelsen; Annette Dam Fialla; Anita Sylvest Andersen; Peter Kampmann; Anne-Mette Hvas

Venøs tromboembolisk sygdom ved COVID-19

Maja Hellfritzsch, Thomas Kümler, Anette Tarp Hansen, Marianne Tang, Kasper Gymoese Berthelsen, Annette Dam Fialla, Anita Sylvest Andersen, Peter Kampmann, Anne-Mette Hvas

Abstract

The importance of venous thromboembolism (VTE) as a major complication in patients with severe corona virus disease 2019 (COVID-19) is becoming increasingly evident. In this review, we describe the proposed pathophysiology of the prothrombotic coagulation changes observed in patients with COVID-19. Further, based on a review of the currently available evidence on VTE prevalence in patients with COVID-19, we present and discuss the recommendations from the Danish Society of Thrombosis and Haemostasis on the use of thromboprophylaxis in patients with COVID-19.

Bidragets oversatte titel	Venous thromboembolism in patients with COVID-19
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	182
Udgave nummer	23
ISSN	0041-5782
Status	Udgivet - 1 jun. 2020

Emneord

Anticoagulants
Betacoronavirus
COVID-19
Coronavirus
Coronavirus Infections
Humans
Isoflavones
Pandemics
Pneumonia, Viral
Pulmonary Embolism
SARS-CoV-2
Venous Thromboembolism

Citationsformater

@article{f147c1fcf3714cd981555fa809ca0c55,

title = "Ven{\o}s tromboembolisk sygdom ved COVID-19",

abstract = "The importance of venous thromboembolism (VTE) as a major complication in patients with severe corona virus disease 2019 (COVID-19) is becoming increasingly evident. In this review, we describe the proposed pathophysiology of the prothrombotic coagulation changes observed in patients with COVID-19. Further, based on a review of the currently available evidence on VTE prevalence in patients with COVID-19, we present and discuss the recommendations from the Danish Society of Thrombosis and Haemostasis on the use of thromboprophylaxis in patients with COVID-19.",

keywords = "Anticoagulants, Betacoronavirus, COVID-19, Coronavirus, Coronavirus Infections, Humans, Isoflavones, Pandemics, Pneumonia, Viral, Pulmonary Embolism, SARS-CoV-2, Venous Thromboembolism",

author = "Maja Hellfritzsch and Thomas K{\"u}mler and Hansen, {Anette Tarp} and Marianne Tang and Berthelsen, {Kasper Gymoese} and Fialla, {Annette Dam} and Andersen, {Anita Sylvest} and Peter Kampmann and Anne-Mette Hvas",

year = "2020",

month = jun,

day = "1",

language = "Dansk",

volume = "182",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "23",

}

TY - JOUR

T1 - Venøs tromboembolisk sygdom ved COVID-19

AU - Hellfritzsch, Maja

AU - Kümler, Thomas

AU - Hansen, Anette Tarp

AU - Tang, Marianne

AU - Berthelsen, Kasper Gymoese

AU - Fialla, Annette Dam

AU - Andersen, Anita Sylvest

AU - Kampmann, Peter

AU - Hvas, Anne-Mette

PY - 2020/6/1

Y1 - 2020/6/1

N2 - The importance of venous thromboembolism (VTE) as a major complication in patients with severe corona virus disease 2019 (COVID-19) is becoming increasingly evident. In this review, we describe the proposed pathophysiology of the prothrombotic coagulation changes observed in patients with COVID-19. Further, based on a review of the currently available evidence on VTE prevalence in patients with COVID-19, we present and discuss the recommendations from the Danish Society of Thrombosis and Haemostasis on the use of thromboprophylaxis in patients with COVID-19.

AB - The importance of venous thromboembolism (VTE) as a major complication in patients with severe corona virus disease 2019 (COVID-19) is becoming increasingly evident. In this review, we describe the proposed pathophysiology of the prothrombotic coagulation changes observed in patients with COVID-19. Further, based on a review of the currently available evidence on VTE prevalence in patients with COVID-19, we present and discuss the recommendations from the Danish Society of Thrombosis and Haemostasis on the use of thromboprophylaxis in patients with COVID-19.

KW - Anticoagulants

KW - Betacoronavirus

KW - COVID-19

KW - Coronavirus

KW - Coronavirus Infections

KW - Humans

KW - Isoflavones

KW - Pandemics

KW - Pneumonia, Viral

KW - Pulmonary Embolism

KW - SARS-CoV-2

KW - Venous Thromboembolism

M3 - Tidsskriftartikel

C2 - 32515339

SN - 0041-5782

VL - 182

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 23

ER -

Venøs tromboembolisk sygdom ved COVID-19

Abstract

Emneord

Fingeraftryk

Citationsformater